Comparative Effectiveness of Depot and Oral Second Generation Antipsychotic Drugs in Schizophrenia: A Nationwide Study in Hungary

European Neuropsychopharmacology - Netherlands
doi 10.1016/j.euroneuro.2013.02.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Review: New Generation Antipsychotic Drugs May Reduce Relapse Rates More Effectively Than Conventional Antipsychotic Drugs in People With Schizophrenia

Evidence-Based Mental Health
PsychiatryMental Health
2004English

Thirty Years of Scientific Research on Second-Generation Antipsychotic Drugs in Japan: A Bibliometric Analysis

Open Journal of Psychiatry
2013English

Clinical Efficacy of Antipsychotic Drugs in the Treatment of Schizophrenia

Journal of Cytology & Histology
2014English

Chlorpromazine Versus Atypical Antipsychotic Drugs for Schizophrenia

2013English

Treatment Adherence and Social Functioning in Patients Diagnosed With Schizophrenia and Treated With Antipsychotic Depot Medication

Medicine and Pharmacy Reports
Medicine
2014English

Second-Generation Antipsychotic Agents in the Treatment of Acute Mania

Archives of General Psychiatry
2007English

Pharmacoeconomic Comparison of Ziprasidone With Other Atypical Oral Antipsychotic Agents in Schizophrenia

Farmeconomia. Health economics and therapeutic pathways
2011English

Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study

British Medical Journal
Medicine
2016English

Response to Antipsychotic Drugs in Treatment-Resistant Schizophrenia: Conclusions Based on Systematic Review

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy